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A major step in the pathogenesis of Mycobacterium tuberculosis is the ability to survive inside macro-
phages, where it is exposed to a number of DNA damaging agents. The alternative sigma factor SigG has
been shown to be upregulated by DNA damaging agents and by macrophage infection, but not to regulate
genes of the DNA repair pathway. Here we show that SigG is expressed from at least two promoters, the
most dominant of these being the DNA damage inducible RecA_Ndp promoter. This promoter is located
within the annotated coding region of SigG and so the correct translational start site was determined
experimentally and found to be 114 bp downstream of the annotated start site. Examining the gene
expression proﬁle of a SigG over-expression strain found a small number of genes to up-regulated, two of
these encoded proteins containing glyoxylase-like domains.
 2013 The Authors. Published by Elsevier Ltd. All rights reserved.1. Introduction
Despite the availability of treatments and a vaccine Mycobacte-
rium tuberculosis remains a major cause of human disease
worldwide and was responsible for 1.4 million deaths in 2011.46
During the course of infection and transmission to new hosts
M. tuberculosis is exposed to a number of stresses and its ability to
adapt to these stresses is a key component of its survival. Not sur-
prisingly the genome sequence ofM. tuberculosis revealed over 100
genes encoding regulatory proteins involved in gene expression,
including 13 sigma factors.9,12 Sigma factors are components of RNA
polymerase that contain the promoter recognition domains. There
are several different classes of sigma factor ranging from house-
keeping sigma factors to the alternative sigma factors, which
respond to speciﬁc external stimuli (reviewed in Helmann et al.23).r the terms of the Creative
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Published by Elsevier Ltd. All righTheM. tuberculosis genome encodes 10 alternative sigma factors38;
here we examine the alternative sigma factor, SigG.
Determining the conditions that induce expression of a partic-
ular alternative sigma factor can be useful in designating function.
SigG is induced byDNA damage and is part of the RecA independent
DNA damage response.36,39 There are two known pathways for
induction of DNA repair genes in response to DNA damage in
M. tuberculosis.15,36 One of these is the classical SOS response that is
controlled by LexA and RecA controlling genes involved in DNA
damage induced mutagenesis, cell cycle control and containing
phage attachment sites.14,17,29,41 The other is the RecA-independent
response that controls the majority of DNA damage inducible
genes, includingmany of the genes involved in DNA repair.36 A DNA
motif resembling a non-canonical promoter common to a number
of genes regulated in this way has been identiﬁed leading to the
suggestion that these genes were controlled by an alternative sigma
factor.21 However, SigG was found not to control transcription of
either the SOS or RecA-independent response genes, and mutation
of sigG did not increase sensitivity to DNA damage.39 The RecA-
independent DNA damage response was subsequently found to
be regulated by the Clp protease regulator ClpR.45
We sought to determine a role for SigG both by looking at the
control of its expression and by determining the genes that SigG
itself regulates. In our previous work we attempted to compare
gene expression in a sigGmutant strain to wild-typeM. tuberculosis
H37Rv but found no signiﬁcant differences,39 possibly due to SigG
being the lowest expressed of all sigma factors under normalts reserved.
A. Gaudion et al. / Tuberculosis 93 (2013) 482e491 483growth conditions.25 Therefore, in this study we examined the
regulon of sigG using an over-expression strain. We found that
instead of controlling genes involved in DNA repair it controls
genes with a potential role in detoxiﬁcation.
2. Materials and methods
2.1. Bacterial strains and culture conditions
The mycobacterial strains used were Mycobacterium smegmatis
mc2155,42 M. tuberculosis wild-type strain H37Rv31 sigG mutant
strains in H37Rv DsigG1 and DsigG2,39 and a sigG operon deletion in
H37Rv DsigGWO (this study). Mycobacterial cultures grown in
Dubos medium (Difco) supplemented with albumin and 0.2%
glycerol or on Difco Middlebrook 7H11 agar plates (Beckton Dick-
enson) supplemented with 4% albumin and 0.5% glycerol.
M. tuberculosis liquid cultures were grown at 37 C in a rolling
incubator at 2 rpm. All procedures with live M. tuberculosis were
carried out under ACDP containment level 3 conditions. Antibiotics
were added as appropriate: kanamycin was used at 25 mg ml1,
hygromycin was used at 50 mg ml1. To induce DNA damage cul-
tures were divided into two aliquots at an OD600 0.3e0.4 and one
sample was treated with 0.02 mg ml1 mitomycin C for 24 h. The
other sample was incubated in parallel without treatment to pro-
vide an uninduced control. The plasmids and primers used in this
study are described in Supplementary Tables 1 and 2 respectively.
Site-directed mutagenesis was performed using the Quikchange
site-directed mutagenesis (SDM) kit (Stratagene). All plasmids
were veriﬁed by DNA sequencing.
2.2. Protein preparation and antibody production
Recombinant SigG was produced by expression of His-tagged
M. tuberculosis SigG from plasmid pJH05 in Escherichia coli strain
Tuner. Protein was puriﬁed using an ÄKTA prime (Amersham Bio-
sciences) ﬁrst using a nickel-loaded HiTrap chelating HP column
(GE Healthcare), followed by puriﬁcation with a HiLoad 26/60
Superdex 200 prep grade gel ﬁltration column (GE Healthcare).
Pure SigG was then used to immunise rabbits to produce polyclonal
anti-SigG antibody by BioServ UK Ltd (Shefﬁeld University); spec-
iﬁcity was determined by Western blot against M. tuberculosis cell
free extract.
2.3. Preparation of cell free extracts, Western blot and b-
galactosidase assays
Cell free extracts were produced as described previously.14 The
supernatants were ﬁltered through a low-binding Durapore 0.22-
mm-pore-size membrane ﬁlter (Ultrafree-MC; Millipore) to ensure
complete removal of bacteria before removal from containment
facilities.
Western blots were performed using rabbit anti-SigG at 1:1000
dilution and anti-rabbit conjugated to horseradish peroxidase
(Dako), at a 1:5000 dilution, or using Penta-His HRP conjugated
antibody at a 1:5000 dilution (Qiagen). The blot was developed
using ECL Western blotting detection reagents (GE Healthcare).
For b-galactosidase activity, protein levels of cell-free extracts
were quantiﬁed using a BCA kit (Pierce) and b-galactosidase activity
was determined as described14 and expressed in Miller units per
milligram of protein.27
2.4. RNA extraction
RNA was prepared from mycobacteria using the FastRNA Pro
Blue kit (Qbiogene). Contaminating DNA was removed usingRNase-free DNase (Roche), and RNA puriﬁed using RNeasy Minikit
(QIAgen), or with a TURBO DNA-free kit (Ambion). RNA quality
was determined using an Agilent Bioanalyser 2100 (Agilent
Technologies).
2.5. Transcriptional start site mapping
Primer extension was carried out using Primer Extension Sys-
tem (Promega). Brieﬂy, primer sigGPExt (Supplementary Table 2)
was end-labelled with 32P-ATP and extension reactions carried out
using 40e100 mg RNA. Reactions were run on an 8% denaturing
polyacrylamide gel, alongside sequencing reactions (T7 Sequenase
Kit Amersham), and visualised using autoradiography. The tran-
scriptional start site of Rv0887c was mapped using the GeneRacer
kit (Invitrogen) for RNA ligase-mediated rapid ampliﬁcation of 50
cDNA ends. Brieﬂy the GeneRacer Oligo (Invitrogen) was ligated to
the 50-ends of RNA from M. tuberculosis H37Rv. cDNA products for
the genes of interest were produced by RT-PCR using a primer
speciﬁc to the GeneRacer Oligo along with a gene speciﬁc primer
(Supplementary Table 2). Ampliﬁed cDNA ends were cloned into
pCR 4-TOPO (Invitrogen) for sequencing.
2.6. Microarray
Whole genome M. tuberculosis microarray slides were obtained
from the Bacterial Microarray Group at St. George’s, London. Cy5-
labelled RNA versus Cy3-labelled DNA hybridizations were per-
formed and analysed as previously described.19,39 Signiﬁcant dif-
ferences were determined using two-way ANOVA with the
Benjamini and Hockberg False Discovery Rate correction. Fully
annotated microarray data have been deposited in BmG@Sbase
(accession number TBC) and ArrayExpress (accession number TBC).
2.7. Quantitative RT-PCR
cDNA synthesis was performed using Superscript II (Invitrogen)
and random hexamer primers. Real-time quantitative PCR was
carried out using Fast SYBR green master mix (Applied Biosystems)
on an Applied Biosystems 7500 Fast instrument and analysed with
7500 Fast SDS software version 1.4. Gene speciﬁc primers (see
Supplementary Table 2) were designed using Primer Express
version 3.0 (Applied Biosystems). For each gene cDNA samples (and
their RT negative controls) were run along with a set of genomic
DNA standards to give a quantity of speciﬁc cDNA per sample.
Values for the RT negative controls were subtracted, followed by
normalisation to the corresponding value of the housekeeping gene
rrs encoding 16s rRNA or sigA, to give relative expression level.
Where required the relative expression of each sample was divided
by that of the untreated sample or empty vector control to give the
induction ratio.
2.8. Murine bone marrow-derived macrophage (BMDM) infection
model
Infection of BMDM was carried out as previously described.20
Monocytes were isolated from the hind legs of female 6e8 week
old BALB/c mice, allowed to differentiate into macrophages for 6
days and ﬂushed from Petri dishes as described previously.43
Macrophages were seeded into 24-well plates at a density of
2  105 cells per well. To activate macrophages 10 ng ml1 murine
interferon-g (IFN-g; Roche) was added. Naïve and activated mac-
rophages were infected with M. tuberculosis strains grown to mid-
log (OD600w 0.5) and resuspended in PBS containing 0.05% Tween
80 at an MOI of 0.1:1. Survival and multiplication of M. tuberculosis
was determined by calculating CFU’s at time points post infection.
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3.1. Characterisation of the SigG operon
As a ﬁrst step in the characterisation of SigG, we conﬁrmed its
genetic organisation. The gene immediately upstream of sigG is
transcribed in the opposite orientation, and downstream there are
three genes transcribed in the same orientation (Figure 1A). Ex-
amination of correlated gene expression predicts that an operon
runs from sigG-Rv0180c, missing lprO (Pearsons correlation coefﬁ-
cient 0.37 sigG-Rv0180c, 0.08 sigG-lprO, TB database www.tbdb.
org). We conﬁrmed this to be the case by RT-PCR (Figure 1) using
a series of primers spanning from the beginning of sigG to the end
of lprO. Transcripts could be obtained from sigG to primer lprOR1
located 250 bp within lprO as well as from the end of Rv0181c to
lprOR1, but not to the 30 end of lprO indicating that the operon
terminates within lprO. A further transcript could be detected be-
tween the 30 end of lprO and 300 bp upstream of the Rv0180c stop
codon. Therefore, the sigG operon consists of sigG, Rv0181c and
Rv0180c, while the lprO transcript starts from a promoter internal to
Rv0180c.
3.2. Determining sigG transcriptional start sites
To determine potential promoters for the sigG operon the tran-
script start sites were mapped by primer extension using RNA
extracted from wild-type M. tuberculosis H37Rv and DsigG1 strains
grown with and without mitomycin C treatment (Figure 2A). This
revealed three potential start sites located at 12, þ57 and þ114 bp
from the annotated start codon of sigG, labelled P3, P2 and P1Figure 1. Co-transcription of sigG, Rv0181c and Rv0180c but not lprO. (A) Schematic repre
Includes positions of primers used in RT-PCR. (B) RT-PCR showing co-transcription of sigG o
sigG transcript terminates within lprO between primer sets 1 and 2 and that lprO transcript
genomic DNA PCR control; sizes of DNA markers are indicated.respectively. P1 shows induction by the DNA damaging agent, mito-
mycin C, and also gives the strongest band both with and without
mitomycin C treatment. P2 and P3 give much weaker bands with P2
showing some induction by mitomycin C and P3 being potentially
SigG dependent, being only identiﬁed fromwild-type RNA.
3.3. Mapping SigG translational start site
As both P1 and P2 are located downstream of the annotated
translational start site of sigG, this site must be incorrect. Located
immediately downstream of P1 are 2 potential GTG start codons
(Figure 2F). To determine if one of these is the start codon for sigG
we performed a frame-shift mutagenesis translational start site
assay as previously described.40 Due to the low expression of SigG
during normal growth25 protein could not be detected. Instead a
SigG over-expression construct, pKS09, was developed. This
plasmid was derived from the moderate copy number plasmid
pMV26144 and contains the entire sigG annotated coding region
plus 500 bp upstream, to include its own regulatory elements (see
Supplementary Table 1). This region also contains a signiﬁcant
proportion of the upstream gene Rv0183 (Figure 2B). Quantitative
RT-PCR analysis found substantial over-expression of sigG when
transformed into wild-type M. tuberculosis H37Rv. Expression of
Rv0181c and Rv0180c was unaffected in this strain (Figure 2C),
indicating that the genomic sigG operon was not over-expressed.
Further RT-PCR analysis found that this transcript started within
the vector sequence (data not shown) indicating that sigG over-
expression was due to read-through from a vector encoded pro-
moter and not auto-regulation by SigG. Western blot on cell free
extract obtained from this strain, using polyclonal antibody againstsentation of M. tuberculosis genomic region containing Rv0182 (sigG)-Rv0179c (lprO).
peron. Transcript was detected using primer sets 1, 3 and 4 but not 2 and 5 indicating
ion starts within Rv0180c. þ shows RT positive;  shows RT negative control; D shows
Figure 2. Transcriptional and translational analysis of sigG. (A) Primer extension analysis using primer sigGPExt, located within the sigG annotated coding region. RNA was isolated
from wild-type M. tuberculosis H37Rv and DsigG1 with and without treatment with 0.02 mg ml1 mitomycin C (MitC) for 16 h. (B) Schematic of sigG operon and Rv0183 gene
organisation showing region contained within pKS09 (SigG over expression construct, highlighted in grey) and position of Rv0183 primers used in (C). (C) qRT-PCR showing
expression of sigG, Rv0181c, Rv0180c and Rv0183 from primers located outside (1) or within (2) pKS09 in wild-type H37Rv containing the SigG over-expression construct (pKS09) or
empty vector (pKS12). Data shows expression normalised to sigA, mean þ standard deviation for 3 biological replicates. (D) Western blot analysis using anti-SigG antibody of three
colonies of wild-type H37Rv containing the SigG over-expression construct (pKS09) or empty vector (pKS12). Sizes of marker bands are indicated. (E) Translational start site assay.
Western blot using anti-SigG antibody against cell free extracts from M. smegmatis containing no vector (WT), or M. smegmatis containing pKS09 SigG over-expression construct
(OE), pKS09TTSmut1 (1) or pKS09TTSmut2 (2) translational start site frame shift mutations of SigG, deletions as indicated in (F). Equal loading was veriﬁed by Coomassie Blue
staining of a similar gel (shown below Western blot). The expected sizes for SigG starting at the annotated start site (41 kDa), or the experimentally determined start site (37 kDa)
are indicated. (F) DNA sequence of promoter region of sigG showing position of transcriptional start sites identiﬁed in (A), P1, P2 and P3 with potential promoter regions underlined,
annotated start codon bold italics, experimentally determined start codon BOLD CAPITALS, and location of single base pair deletions used in (D) mut1 and mut2.
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smaller than expected from the annotation (Figure 2D). Two indi-
vidual single base pair deletions were made in this construct
immediately up or downstream of the 1st potential GTG start codon
downstream of P1, termed pKS09TTSmut1 and pKS09TTSmut2
respectively (Figure 2F). These constructs were expressed in
M. smegmatis, which has been shown to be a suitable model for
determining translational start codons ofM. tuberculosis proteins.40
Western blots were performed on cell-free extracts obtained fromthese strains grown to mid-log phase, and equal loading was
determined by Coomassie staining of an equivalent gel (Figure 2E).
SigG was undetectable in wild-type M. smegmatis, whereas the
over-expression construct gave high levels of SigG protein. SigG
could be detected in pKS09TTSmut1 but was not detectable with
pKS09TTSmut2. This indicates that the translational start site for
SigG is between these two mutations and so must be located at the
GTG 114 bp downstream of the annotated start codon resulting in a
protein 38 amino acids shorter.
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SigG translation starts immediately downstream of P1, which
corresponds with the previously identiﬁed RecA_NDp promoter21
(Figure 2F). To determine whether each of the potential pro-
moters were active, transcriptional fusions for each promoter were
constructed fusing approximately 60 bp upstream of each tran-
scriptional start site to the reporter gene lacZ, giving plasmids
pLDlac1, pLDlac2 and pLDlac3 (containing P1, P2 and P3 respec-
tively, Figure 3E). The promoter activity for each construct was
determined in wild-type M. tuberculosis H37Rv with and without
mitomycin C treatment (Figure 3A). Only P1 gave activity above
background and this was increased approximately 3-fold upon DNA
damage induction. An A to C mutation was made in the 10 region
of RecA_NDP of P1 giving pLDlac1-mut. This mutation is known to
inactivate this promoter family22 and abolished the activity from
the P1 promoter. Therefore, promoter 1 is active and is responsible
for DNA damage induction of the sigG operon. To determine
whether the other potential promoters play a role in expression of
sigG, pGA04 was constructed, containing all 3 potential promoters
fused to the reporter gene lacZ (Figure 3E). This longer construct
could also contain binding sites for other potential regulatory ele-
ments necessary for activity that may be missing in the smaller
constructs. Mutations weremade in the10 region of P1 (as above)Figure 3. Promoter activity for sigG. (A) b-galactosidase activity for M. tuberculosis containing
identiﬁed in Figure 2A to reporter gene lacZ (as indicated in E), pLDlac1 (P1), pLDlac2 (P2) and
(black bars) and without (white bars) treatment with 0.02 mg ml1 mitomycin C. (B) Translatio
WT Pr) with mutations to 10 regions of P1 (pAG04-mut1), P1 and P2 (pAG04-mut2) and P
downstream from P1, detecting transcript from all promoters), and sigGP2qRTF and sigGP2q
upstream of P1). Expression was assessed from wild-type M. tuberculosis H37Rv with (blac
b-galactosidase activity for pAG04, containing the full length sigG promoter inwild-typeM. tube
make construct pAG04 including P1, P2 and P3 with potential 10 and 35 promoter region
constructs are indicated by boxes, together with the transcriptional start site for each promote
codons BOLD ITALIC CAPITALS. Data represents mean þ standard deviation from 3 biological rgiving pAG04-mut1, and also in the10 regions of P2 and P3 giving
plasmids, pAG04-mut2 (P1 and P2 mutation) and pAG04-mut3
(P1, P2 and P3 mutation). The promoter activity for these plasmids
was determined in wild-type M. tuberculosis H37Rv (Figure 3B).
Mutation of the RecA_NDp (pAG04-mut1) reduced but did not
abolish activity from the wild-type promoter (pAG04); while this
was not a signiﬁcant reduction this may be due to the presence or
absence of additional regulatory elements of P1 in the longer
construct. Additional mutation of the 10 region of P2, (giving
pAG04-mut2), reduced this activity further, to approximately 1
quarter that of the wild-type, whereas mutation of P3 had no
additional effect. Therefore sigG is expressed from at least two
promoters. To conﬁrm this at the mRNA level qRT-PCR was per-
formed on RNA isolated from M. tuberculosis H37Rv with and
without mitomycin C treatment (Figure 3C). Primers were located
either downstream of promoter P1, therefore detecting transcripts
originating from all three promoters, or between promoter P2 and
P1, therefore detecting transcripts originating from promoters P3
and P2 only. Detection of transcripts downstream of P1 showed a
high level of expression and was induced 3-fold upon mitomycin C
induction. A similar level of transcript could be detected upstream
using primers located between P1 and P2 but outside of the Rv0183
coding region. This transcript reduced upon DNA damage induc-
tion. The difference between the transcripts detected by the twopEJ414 empty vector (EV), or vectors containing translational fusions of each promoter
pLDlac3 (P3) and P1 containing a mutation of the10 region (pLDlac1-mut, P1-mut) with
nal fusion of 339 bp region upstream of sigG containing all 3 putative promoters (pAG04,
1, P2 and P3 (pAG04-mut3). (C) qRT-PCR using primers sigGqRTF and sigGqRTR (located
RTR (located between transcriptional starts sites P1 and P2, detecting transcript starting
k bars) and without (white bars) mitomycin C treatment and normalised to sigA. (D)
rculosisH37Rv and DsigGWO. (E) 339 bp DNA sequence of promoter region of sigG used to
s shaded grey. Locations of the DNA fragments used in the individual pLDlac promoter
r (arrow and bold) and the annotated (ATG) and experimentally determined (GTG) start
eplicates, statistical signiﬁcance by two-tailed T test (P value * < 0.1, ** < 0.01).
A. Gaudion et al. / Tuberculosis 93 (2013) 482e491 487primer sets is most likely directly due to the activity of promoter P1.
Therefore under DNA damaging conditions P1 is the primary pro-
moter for the sigG operon. One other promoter possibly also con-
trols expression of sigG, however, due to the proximity of the
Rv0183 and sigG coding regions, the sigGP2qRTF primer is located
only 37 bp upstream of the annotated Rv0183 coding region. It is
therefore possible that the transcript detected upstream of sigG
promoter P1 is actually the Rv0183 transcript.
Primer extension analysis indicated that P3 was potentially SigG
dependent (Figure 2A); however, over-expression of SigG did not
affect expression from the rest of the sigG operon, suggesting that
expression of the genomic operon is not SigG dependent
(Figure 2C). Therefore we examined activity of the SigG promoter
region in DsigGWO, in which the SigG-Rv0180c operon was deleted
and replaced with a gentamicin resistance cassette by homologous
recombination (Supplementary Figure 1A). The ﬁrst 32 bp of sigG
and last 380 bp of Rv0183 were included in the targeting construct
to prevent effects on the promoters of adjacent genes. The absence
of expression of sigG, Rv0181c and Rv0180c in DsigGWO was
conﬁrmed by qRT-PCR (Supplementary Figure 1B). The sigG pro-
moter construct pAG04, containing all three potential promoters
was expressed in DsigGWO, but showed no difference in activity
compared to expression in wild-type M. tuberculosis (Figure 3D).
The dominant P1 promoter could be masking the effects of a sigG
dependent promoter. However, it is possible that lack of detection
of the P3 transcriptional start site in DsigG1 is due to a defect in this
strain, which also contains a spontaneous mutation affecting the
cell wall.39
3.5. Investigation of the role of SigG in vivo
The potential role of SigG during in vivo infection was assessed
in a macrophage infection model. Wild-type H37Rv, DsigG2 and
DsigGWO, were used to infect naïve and activated murine bone
marrow derived macrophages (BMDM). Neither the DsigG2 or
DsigGWO strains were attenuated compared to wild-type
(Figure 4).
3.6. Identiﬁcation of the SigG regulon
The possible function of SigG was further assessed by deter-
mining its regulon. Previous investigations examining the gene
expression proﬁles of a sigG mutant strain with and without DNA
damage induction found no signiﬁcant differences from the wild-
type H37Rv strain.39 Therefore, in this investigation we compared
the expression proﬁles ofM. tuberculosisH37Rv containing pKS09, a
SigG over-expression construct, to that of H37Rv containing an
empty vector (pKS12) by microarray (Table 1). This identiﬁed 13
genes signiﬁcantly up-regulated in the over-expression strain by
more than 1.75 fold (P value < 0.05). The two most upregulated
genes were sigG and Rv0183. A signiﬁcant portion of Rv0183 isFigure 4. SigG does not affect survival of M. tuberculosis during infection of macrophages.
naïve and activated BMDMs. Data represents the mean þ standard deviation of 3 biologicalocated within the pKS09 construct used for over-expression (see
Figure 2B). Quantitative-PCR was performed using two sets of
primers, one located either within Rv0183 and contained in pKS09
(primer set 2), the other within Rv0183 but outside of the region
contained in pKS09 (primer set 1). This conﬁrmed that the higher
level of Rv0183 RNA observed in the microarray analysis is an
artefact of the over-expression strain and not speciﬁc regulation by
SigG (Figure 2C). Rv0181c and Rv0180c were not identiﬁed as being
upregulated in pKS09, which conﬁrmed previous qRT-PCR analysis
(Figure 2C) and shows further shows that SigG is not autor-
egulatory. Quantitative PCR conﬁrmed that 9 of the remaining 11
genes were upregulated more than 1.5-fold compared to an empty
vector strain (Table 1). To conﬁrm whether these genes identiﬁed
by microarray analysis were upregulated due speciﬁcally to the
SigG protein, or artefacts of the over-expression construct, induc-
tion relative to the empty vector containing strain was assessed in
H37Rv containing pKS09FS, inwhich a single base pair deletionwas
made within the coding region of sigG. This resulted in a strain
which gave the same level of RNA but no functional SigG protein
due to a frame-shift (Table 1). Induction of Rv0942, vapB15, vapC15,
gabD1 and Rv2004 occurred in both the SigG overexpression
(pKS09) and frame-shift (pKS09FS) strains and so most likely
represent false positives. The vapBC15 operon encodes a toxin-anti-
toxin system, the toxin of which degrades mRNA and has been
shown to be induced during stress such as hypoxia.33 This operon
may be instead responding to the abnormal pattern of RNA
expression rather than to SigG itself. Induction of fprB, Rv0887c,
Rv0911, Rv0912, prpD and inhAwas signiﬁcantly reduced in the SigG
frame-shift (pKS09FS) compared to functional SigG overexpression
(pKS09) indicating that their induction was dependent on func-
tional SigG protein.
The two genes most highly induced by SigG were Rv0887c (16-
fold induction) and Rv0911 (11-fold induction). These are both an-
notated as conserved hypothetical proteins of unknown function,
however, analysis of their sequence structure identiﬁed that they
both contain Glo_EDI_BRP_like superfamily domains (Figure 5A).
These domains are characteristic of glyoxalases, type I extradiol
dioxygenases and bleomycin resistance proteins, which are all
involved in inactivation of toxic compounds, many of which dam-
age DNA.18 Expression of Rv0887c in response to DNA damage by
mitomycin C was assessed inwild-type H37Rv and DsigG2, inwhich
sigG is mutated, without the spontaneous cell wall mutation39 and
DsigG2 containing the pLDL-8T complementing vector, containing
the entire sigG operon (Figure 5B). Expression of Rv0887cwas found
to increase upon mitomycin C treatment in the wild-type H37Rv
strain (induction ratio 5.7, p-value <0.05). Expression in the DsigG2
mutant was 3.6-fold lower than wild-type without induction, and
no increase in expressionwas seen after treatment with mitomycin
C (induction ratio 1.5, p-value > 0.1). Expression in the com-
plementing strain was similar to wild-type (induction ratio 3.9,
p-value< 0.05). There was also a slight, but not signiﬁcant, increaseSurvival and multiplication of M. tuberculosis H37Rv, mutants DsigG2 and DsigGWO in
l replicates.
Table 1
Genes upregulated in SigG over-expression strain. Genes found to be upregulated in SigG over-expression strain microarray analysis. Direct regulation by SigG was conﬁrmed
by qRT-PCR. Genes positively regulated by functional SigG are shown in bold.
Rv number Gene name Microarrayy qRT-PCRz Protein function
Fold-change p-Value pKS09 pKS09FS
Rv0182 sigG 110.22 4.11  1008 473.1 443.9 Alternative RNA polymerase sigma factor
Rv0183 52.52 2.81  1004 ND ND Lysophospholipase
Rv0887c 15.96 2.36  10L06 229.9 1.87** Conserved hypothetical protein
Rv0911 11.37 3.13  10L07 12.13 1.297* Conserved hypothetical protein
Rv0886 fprB 10.89 3.13  10L07 6.72 1.68** NADPH:adrenodoxin oxidoreductase
Rv0912 6.45 4.63  10L04 2.22 1.04** Conserved transmembrane protein
Rv1130 prpD 1.93 0.042 2.44 0.58* Methylcitrate dehydratase
Rv1484 inhA 1.78 0.0073 1.96 1.05** NADH-dependent enoyl-[acyl-carrier-protein] reductase
Rv0942 4.93 0.0014 1.22 1.04 Hypothetical protein
Rv0234c gabD1 2.05 0.019 1.64 1.45 Succinate-semialdehyde dehydrogenase
Rv2004c 1.98 0.027 0.46 0.64 Conserved hypothetical protein
Rv2009 vapB15 1.98 0.027 2.81 2.45 Anti-toxin
Rv2010 vapC15 1.93 0.022 2.32 1.98 Toxin
y Microarray analysis performed with three biological and two technical replicates; fold change compared to empty vector containing wild-type M. tuberculosis H37Rv;
genes upregulated >1.75 fold with Benjamini Hochberg corrected p-value < 0.05.
z qRT-PCT from at least three biological replicates; relative expression normalised to that of sigA; fold-change for SigG over-expression (pKS09), or SigG frameshift mutant
(pKS09FS) compared to empty vector containing wild-type M. tuberculosis; signiﬁcant differences between expression in pKS09 compared to pKS09FS containing strains
determined by T-test (p < 0.1 ¼ *; p < 0.01 ¼ **).
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H37Rv, which was reduced in the mutant (data not shown). This
indicates that expression and DNA damage induction of Rv0887c is
dependent on SigG.
The transcriptional start site of Rv0887c was mapped using 5’
RACE in wild-type H37Rv expressing pKS09. This identiﬁed a po-
tential start site 52 bp upstream of the annotated start codon
(Figure 5C). This region showed signiﬁcant homology to the pro-
moter region of Rv0911 and was used to identify a potential pro-
moter motif for SigG as being CGATGA(N18)GTCNNTA.
4. Discussion
We examined the regulation of sigG at the transcriptional level,
as well as determining the regulon for SigG. The dominant pro-
moter for sigGwas found to coincide with the RecA_NDp promoter.
This promoter is located downstream of the annotated start site for
sigG indicating that this site must be incorrect. Due to the GC rich
genome incorrect annotation of translational start codons is com-
mon in Mycobacteria, which has implications for predictions of
promoters and gene function.40 Translational start site mapping of
SigG revealed that the start codon is in fact located 114 bp down-
stream of the annotated start codon, producing a protein 38 amino
acids shorter. This region does not contain any of the functional
domains for the sigma factor. Codon usage database analysis30
found that this region contained 7 (18.4%) codons which occur at
a frequency less than 5 per 1000 for the entire M. tuberculosis
protein coding genes, compared to 15 (4.5%) in the rest of the sigG
gene. This may mean that this region is much less able to be
translated. The alternative sigma factor, SigE, was shown to start
from three different codons depending on the promoter used,16 it is
therefore possible that SigG is expressed from the annotated start
codon under different growth conditions. The DNA damage
inducible promoter for SigG is the furthest downstream, therefore if
SigG was also able to start from two translational start codons you
would expect the protein expressed under DNA damaging condi-
tions to be smaller than that expressed under normal, exponential
growth. In fact there was no evidence of any larger isoforms from
over-expression of SigG in either M. smegmatis or M. tuberculosis
(Figure 2). It was also noted that expression of soluble recombinant
SigG in E. coli could only be obtained when this regionwas omitted
from the expression construct (data not shown). This indicates that
SigG likely starts from this site under all conditions.This study identiﬁed three potential promoters upstream of the
experimentally determined SigG translational start site, including
the previously characterised DNA damage inducible RecA_NDp,
recognised by ClpR.21,45 Expression of sigma factors from multiple
promoters has been shown previously for SigB, SigC, SigE and
SigL.11,13,38 We were able to demonstrate the activity and DNA-
damage inducible nature of promoter P1; however, when
included in the longer lacZ construct, mutation of the P110 region
did not signiﬁcantly reduce expression levels. This is likely due to
the presence of regulatory elements in this longer construct that
were not present in the individual promoter constructs. We were
unable to ascertain whether promoters 2 and 3 were genuine; both
promoters showed no activity when expressed individually, and
the longer construct, containing potential binding sites for other
regulatory elements, showed only a slight reduction in activity
when promoter 2 was mutated. It’s possible that the mutations
used did not completely eliminate activity or an additional,
uncharacterised promoter is responsible for the residual activity.
Initial primer extension analysis indicated that promoter 3 was
SigG dependent, however this is unlikely to be the case as over-
expression of SigG had no effect on expression from its own pro-
moter (as expression of the rest of the operonwas unaffected); also
promoter activity was unaffected in a SigG mutant strain
(Figure 3D). Promoter 3 does, however, bear some similarity to the
SigM consensus, which has been shown to be induced during
temperature stress and stationary phase and regulate genes
involved in oxidative stress and secretion.2,4,35
sigG was found to be transcribed in a three gene operon with a
long 30 untranslated region overlapping the downstream gene lprO.
Whole genome sequencing has revealed that long 30 UTR’s are
common in M. tuberculosis.3 In most bacteria termination is tightly
regulated by a hairpin loop structure followed by a poly-U-stretch,
conversely mycobacterial terminators lack the poly-U-stretch
which may result in less efﬁcient termination and have implica-
tions for the regulation of downstream genes.3,28 Interestingly,
when the entire sigG operon, up to 380 bp before the end of
Rv0180c, was deleted an increase in the expression of lprO was
observed (Supplementary Figure 1), indicating that during normal
growth either expression of the sigG operon inhibits lprO expres-
sion or a negative regulatory element for lprO is present within the
deleted section of Rv0180c.
SigG is regulated as part of the DNA damage response of
M. tuberculosis. However, mutation of sigG caused no increase in
Figure 5. SigG regulates 2 potential glyoxylases, Rv0887c and Rv0911. (A) Domain structure of Rv0887c and Rv0911 showing position of Glo_EDI_BRP_like domains. (B) Expression
of Rv0887c analysed by qRT-PCR in wild-type H37Rv, DsigG2 mutant and DsigG2 complement (containing pLDL-8T) with (black bars) and without (white bars) mitomycin C in-
duction. Data shows expression normalised to rrs, mean þ standard deviation for at least 5 biological replicates, statistical signiﬁcance by two-tailed T test (P value * < 0.1, ** < 0.01
and *** < 0.001). (C) 50RACE of Rv0887c yielded a transcriptional start site, which mapped to a G residue 52 bp upstream of the annotated coding region (boxed). CLUSTAL 2.1
alignment of the upstream regions of Rv0887c and Rv0911 showed that this G residue was conserved 40 bp upstream of the annotated start codon of Rv0911 and was located in a
region of strong homology between the two genes. A sigG promoter sequence CGATGA(N18)GTCNNTA was predicted (grey shading) from the alignment. Annotated start codons are
shown in bold.
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regulate the RecA-dependent SOS response, in particular the SOS
response regulator lexA.24 Subsequent investigations found no
difference in the regulation either the SOS response, or RecA-
independent DNA damage response genes in a sigG deletion
mutant, and lexA was found to be controlled by a SigA consensus
promoter.39 Our previous analysis of the transcriptional proﬁle of a
sigG mutant strain in fact showed no signiﬁcant differences to the
wild-type M. tuberculosis.39 We, therefore, looked at genes upre-
gulated with a sigG over-expression strain. This gave ﬁve genes that
were upregulated dependent on functional SigG, as their expres-
sion was no longer increased when a frameshift was introduced
into the SigG coding region: fprB, Rv0887c, Rv0911, Rv0912, inhA and
prpD. In addition, Rv0887c expression was conﬁrmed to be regu-
lated by SigG as its expression and DNA damage induction wasreduced in a sigG mutant strain. No genes previously predicted to
be part of the SOS response or the RecA-independent DNA damage
response were found to be upregulated in the SigG over-expression
strain, further conﬁrming that SigG does not regulate either of
these pathways.
The two genes most highly upregulated in the SigG over-
expression strain were Rv0887c and Rv0911. These encode
conserved hypothetical proteins of unknown function that both
contained glyoxylase-like domains. Glyoxylase is involved in
detoxifying reactive 2-oxoaldehydes, mainly methylglyoxal, a by-
product of glycolysis thought to control the rate of carbon ﬂux
when moving between environments.18 Methylglyoxal can also
cause DNA damage. Rv0911 was predicted to be involved in the
methylglyoxal detoxiﬁcation pathway of M. tuberculosis, as it was
able to interact with pyrimidine-imidazole compounds, which
A. Gaudion et al. / Tuberculosis 93 (2013) 482e491490target the methylglyoxal detoxiﬁcation pathway.26 Proline meta-
bolism has also been predicted to play a role in methylglyoxal
detoxiﬁcation in M. smegmatis.5 Accordingly deletion of PruC, a
transcriptional activator of proline metabolism, resulted in an in-
crease in expression of ﬁve potential glyoxalases, including
MSMEG_5680 the homologue of Rv0887c, as well as sigG and other
genes belonging to the RecA-independent DNA damage induction
pathway. Increased levels of methylglyoxal were found in
M. tuberculosis infected macrophages and granulomas,32 sigG was
found to be upregulated in M. tuberculosis infected macrophages,
and Rv0180c, cotranscribed with sigG, has been shown to be
involved in host cell invasion.8,10 However, a sigG mutant was not
found to be impaired in its ability to infect mice (data not shown) or
macrophages derived from mouse bone marrow (Figure 4). A pre-
vious study did ﬁnd slight attenuation of a sigG mutant during
infection of macrophages.24 This may reﬂect differences in strains
of M. tuberculosis (H37Rv or CDC1551) or cell lines (murine BMDM
or murine macrophage J774A.1) used. There was also no difference
in the susceptibility of a sigG mutant strain to DNA damaging
agents,39 or methylglyoxal toxicity compared towild-type (data not
shown). This could be due to compensation by other sigma factors
or glyoxalases. For example Rv0577 is a predicted glyoxalase that
has been shown to effect T cells to produce a Th1 response and
induce maturation of dendritic cells.7,26 Infection of most mice
strains with M. tuberculosis does not result in the highly organised
granulomas seen in human infection,34,37 and so the role of SigG
may not be as important during infection of mice.
The transcriptional start site of Rv0887c was mapped to a G
residue, 52 base pairs upstream of the annotated start codon.
Alignment of the upstream regions of Rv0887c and Rv0911 showed
signiﬁcant homology between the two and a putative SigG pro-
moter sequence was identiﬁed as CGATGA(N18)GTCNNTA. Previ-
ously a SigG consensus sequence has been hypothesised to be
GCGNGT(N15e18)CGANCA24 however, at least two of the genes,
whose decreased expression in a sigG deletion mutant was used to
suggest theywere part of the SigG regulon, have subsequently been
show to not be SigG regulated: lexA39 and Rv0654 (data not shown).
It is therefore unlikely that this consensus is correct.
Rv0181c, which is cotranscribed with SigG, may also have a
detoxifying role. BLAST analysis revealed that this protein had
signiﬁcant homology to the E. coli YhhW pirin protein (data not
shown). YhhW has been shown to break down the antioxidant,
quercetin, and is therefore a detoxifying enzyme known as a
quercetinase.1 Puriﬁed Rv0181c protein has been shown to have
some quercetinase activity thus supporting its potential role as a
detoxifying enzyme (Supplementary Figure 2). Quercetin is a
member of a group of compounds called ﬂavonoids, which have
been shown to inhibit fatty acid and mycolic acid biosynthesis in
M. tuberculosis.6 In addition the strain DsigGWO showed increased
susceptibility to the presence of Tween 80 compared to the wild-
type strain. This phenotype could be complemented by all three
genes of the sigG operon but not by sigG on its own (Supplementary
Figure 3). This suggests that the susceptibility of the DsigGWO
strain to Tween 80 is due to the absence of either Rv0181c and/or
Rv0180c. Due to the fact that Tween 80 acts as a surfactant and
Rv0180c is an integral membrane protein47 we hypothesise that the
Tween 80 phenotype may be due to the absence of the Rv0180c
gene.
We have shown that sigG is expressed as part of a three gene
operon and its expression is controlled by at least two promoters.
SigG is induced as part of the RecA independent DNA damage
response but is not the sigma factor which controls this
response.39 Instead SigG induces an alternative regulon, possibly
involved in detoxiﬁcation of methylglyoxal. sigG is co-transcribed
with a putative quercetinase and a transmembrane protein. Theabsence of one or both of these two members of the sigG operon
causes M. tuberculosis to become susceptible to the presence of
Tween 80. Taken together, the potential functions of genes co-
transcribed with sigG and members of the SigG regulon, outline
a novel aspect of the DNA damage and stress response in
M. tuberculosis, which, as well as inducing genes involved in DNA
repair, also induces, via SigG, genes possibly involved in detoxi-
fying factors that could be responsible for causing DNA damage
and cell stress.
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